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AMPK regulates basal skeletal muscle capillarization and
VEGF expression, but is not necessary for the angiogenic
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5′-AMP-activated protein kinase (AMPK) is a metabolic fuel sensor that monitors cellular energy
charge, while the vasculature is important for maintaining cellular energy homeostasis. Mice
with muscle-specific inactive AMPK (AMPK DN) were used to investigate if AMPK regulates
skeletal muscle capillarization and the angiogenic responses to exercise. Two hours of the AMP
analogue AICAR (1.0 g kg−1) or systemic hypoxia (6% O2) increased vascular endothelial growth
factor (VEGF) mRNA in wild-type (WT), but not in AMPK DN mice. In contrast, the increase
in VEGF mRNA with acute exercise (1 h at 20 m min−1, 10% gradient) was greater in AMPK
DN compared to WT mice. Nuclear run-on assay demonstrated that exercise increased VEGF
transcription, while hypoxia decreased VEGF transcription. There was no difference in VEGF
transcription between WT and AMPK DN. There was a strong correlation between VEGF
transcription and VEGF mRNA at rest and with exercise. Resting capillarization was lower
in AMPK DN compared to WT. Wheel running (28 days) increased capillarization and this
response was AMPK independent. Significant correlations between VEGF protein and muscle
capillarization are consistent with VEGF being an important determinant of skeletal muscle
capillarization. These data are to our knowledge the first to demonstrate in skeletal muscle in
vivo that: (1) AMPK is necessary for hypoxia-induced VEGF mRNA stabilization, (2) acute
exercise increases VEGF transcription, (3) inhibition of AMPK augments the VEGF mRNA
response to acute exercise, and (4) AMPK regulates basal VEGF expression and capillarization,
but is not necessary for exercise-induced angiogenesis.
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The ability to respond to physiological stressors, such
as reduced intracellular energy charge, is critical for cell
survival. 5′-AMP-activated protein kinase (AMPK) is a
heterotrimeric enzyme, consisting of a catalytic subunit
(α) and two regulatory subunits (β and γ), that acts as a
metabolic fuel gauge to monitor cellular energy charge.
Upon activation, AMPK decreases metabolic flux through
energy-consuming pathways (i.e. fatty acid synthesis) and
initiates energy-conserving/producing processes (i.e. fatty
acid oxidation) (Winder & Hardie, 1999). The increase in
AMPK activity, in response to elevated AMP : ATP ratios,
is accomplished through several interrelated mechanisms
(reviewed in Hardie, 2004). Both allosteric binding of
AMP (Hardie et al. 1998) and phosphorylation by an
upstream AMPK kinase (Sakamoto et al. 2005) contribute
to increase AMPK activity. Metabolic or environmental
stressors that are known to activate AMPK include exercise
(Winder & Hardie, 1996; Hutber et al. 1997; Vavvas
et al. 1997) and hypoxia (Hayashi et al. 2000; Gonzalez
et al. 2004). It is also well established that AMPK can
be activated pharmacologically with the AMP analogue
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside
(AICAR) (Henin et al. 1996; Merrill et al. 1997; Russell
et al. 1999; Musi et al. 2001). Although AMPK is
traditionally known as a metabolic regulatory enzyme, a
growing body of literature suggests that AMPK also plays
other important physiological roles.
It has been hypothesized that the vasculature is
important for maintaining cellular energy homeostasis,
such that the skeletal muscle capillaries are vital for the
delivery of substrates (i.e. oxygen, carbohydrates and fatty
acids) to muscle for ATP synthesis (Adair, 2005). It has
been proposed that skeletal muscle capillarization can be
regulated by metabolic demand and oxidative capacity
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(Hepple et al. 1997; Frisbee, 2005). Angiogenesis, an
expansion of capillaries from existing capillaries, is one
of the many adaptations resulting from chronic exercise
training that may aid in alleviating metabolic stress caused
from repeated bouts of exercise (Hepple et al. 1997;
Richardson et al. 2000); however, the mechanisms that
regulate exercise-induced angiogenesis are not fully under-
stood.
Vascular endothelial growth factor (VEGF) is a
predominantly endothelial cell-specific mitogen that is
an important regulator of basal capillary maintenance
and angiogenesis (Ferrara, 1999). Inhibition of
endogenous VEGF production reduces basal skeletal
muscle capillarization 64% (Tang et al. 2004a), induces
skeletal muscle cell apoptosis (Tang et al. 2004a), and
inhibits skeletal muscle angiogenesis in response to
exercise training (Wagner et al. 2005). It is well established
that skeletal muscle VEGF expression is increased in
response to acute hypoxia (Minchenko et al. 1994; Breen
et al. 1996; Gavin et al. 2006) and exercise (Breen
et al. 1996; Gustafsson et al. 1999; Gavin et al. 2006);
however, the mechanisms that regulate skeletal muscle
VEGF expression remain to be elucidated.
Ouchi et al. demonstrated that AICAR enhances
capillarization and VEGF mRNA and protein in
ischaemic muscle tissue (Ouchi et al. 2005). Additionally,
inactivation of AMPK reduces skeletal muscle blood flow
(indicative of lower vascularization) and VEGF expression
in response to ischaemia (Ouchi et al. 2005). It is unknown
if AMPK regulates exercise-induced VEGF expression or
angiogenesis in skeletal muscle. In the present study, a
mouse model that overexpresses muscle-specific inactive
(dominant negative) AMPK was used to investigate if
AMPK regulates skeletal muscle capillarization and the
angiogenic responses to exercise.
Methods
Animal use
All animal protocols and procedures were approved
by the East Carolina University Animal Use and
Care Committee. Female transgenic mice overexpressing
an inactive AMPK α2 catalytic subunit (termed
AMPK dominant negative; AMPK DN) on a C57BL/6
background were used throughout (a kind gift from
Morris J. Birnbaum, MD, Howard Hughes Medical
Institute, University of Pennsylvania School of Medicine).
The AMPK α2 mutation is driven by the muscle creatine
kinase (MCK) promoter, thus expression of the AMPK
DN transgene is limited to skeletal muscle, and to a
much lesser extent, cardiac muscle. Overexpression of the
inactive AMPK α2 subunit is sufficient to out-compete
binding of endogenous wild-type AMPK α1 and α2
subunits for the AMPK β and γ subunits, thus eliminating
essentially all AMPK activity in skeletal muscle of AMPK
DN transgenic mice (Mu et al. 2001). AMPK DN mice
were identified by PCR analysis of isolated tail DNA
by use of primers specific for the mutated AMPK α2
gene and confirmed by Western blot analysis. AMPK
DN and wild-type (WT) littermate mice were housed
in a temperature-controlled environment (21◦C) with
a 12 : 12 h light : dark cycle and provided food and
water ad libitum. All mice were anaesthetized by iso-
fluorane inhalation and killed by cervical dislocation at
the times indicated. Total number of mice used for these
experiments was WT, n = 70; AMPK DN, n = 89.
Experimental design
AMPK, AICAR and VEGF mRNA. To confirm that AMPK
regulates VEGF mRNA expression in skeletal muscle in
vivo, WT (n = 7) and AMPK DN (n = 6) mice were
given an intraperitoneal injection of the pharmacological
activator of AMPK, AICAR (1.0 g (kg body wt)−1; Toronto
Research Chemicals Inc., North York, Ontario, Canada).
WT (n = 6) and AMPK DN (n = 3) littermates, given a
comparable volume of saline, were used as controls. Two
hours after injection, the gastrocnemius muscles were
rapidly excised, frozen in liquid nitrogen, and stored at
−80◦C until analysis of VEGF mRNA.
AMPK, hypoxia and VEGF mRNA. Because the VEGF
mRNA response to exercise has been proposed to
involve hypoxia (Wagner, 2001), we investigated if AMPK
regulates the VEGF mRNA response to acute systemic
hypoxia by subjecting WT (n = 11) and AMPK DN
(n = 14) mice to 2 h of normobaric systemic hypoxia
(6% O2) by substituting nitrogen for ambient oxygen
with standard pressure and constant flow rate. A gas
analyser (SensorMedics, Anaheim, CA, USA) was used
to continuously monitor oxygen concentrations. This
level of hypoxia was chosen because both VEGF mRNA
(Gavin et al. 2006) and hypoxia-inducible factor-1α
(HIF-1α; an important transcriptional regulator of VEGF)
(Stroka et al. 2001) increase in response to 6% O2 in
skeletal muscle of C57BL/6 mice. Immediately following
hypoxic exposure, gastrocnemius muscles were rapidly
excised, frozen in liquid nitrogen, and stored at −80◦C
until analysis of VEGF mRNA. Resting WT (n = 16) and
AMPK DN (n = 24) littermates breathing normal room
air were used as controls.
AMPK, acute exercise and VEGF mRNA. To investigate
if AMPK regulates the VEGF mRNA response to
acute aerobic exercise, WT and AMPK DN mice were
exercised on a rodent treadmill (Stanhope, Davis, CA,
USA) for 60 min at 20 m min−1, 10% gradient (55% of
maximal treadmill running speed). Preliminary studies
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revealed no difference in maximal treadmill running
speed (36.0 ± 1.4 versus 35.8 ± 1.0 m min−1) or time to
exhaustion (18.0 ± 1.0 versus 17.6 ± 0.7 min) between
WT (n = 4) and AMPK DN (n = 6) mice, respectively.
Therefore, WT and AMPK DN mice were exercised
at the same absolute intensity for the current studies.
We previously reported that the VEGF mRNA response
peaks 1 h after completion of the 60 min of 20 m min−1,
10% gradient treadmill exercise bout in C57BL/6 mice
(Gavin et al. 2006); therefore, gastrocnemius and plantaris
muscles were harvested 1 h post exercise (WT; n = 7 and
AMPK DN; n = 7) for the analysis of VEGF mRNA. The
same set of control WT (n = 16) and AMPK DN (n = 24)
littermate mice from ‘AMPK, hypoxia and VEGF mRNA’
were used as controls for the acute exercise experiments.
AMPK, hypoxia, exercise and VEGF transcription. To
investigate if the increase in VEGF mRNA expression in
response to hypoxia and to exercise in skeletal muscle is the
result of increased transcriptional activity, WT and AMPK
DN mice underwent 2 h of hypoxia (WT n = 4; AMPK DN
n = 6) or 60 min of aerobic exercise (WT n = 3; AMPK DN
n = 3) as described above. Immediately after the respective
treatments, gastrocnemius muscles were rapidly excised
and prepared for nuclear isolation. Resting WT (n = 6)
and AMPK DN (n = 7) littermates, breathing room air,
were used as controls. Due to the large amount of starting
material required for this analysis, nuclear isolation was
performed only from gastrocnemius muscle.
AMPK, exercise-induced angiogenesis and VEGF protein.
To determine if AMPK regulates exercise-induced
angiogenesis and VEGF protein expression, 8-week-old
WT (n = 8) and AMPK DN (n = 10) mice were housed
individually in cages and allowed free access to a rodent
running wheel (12 cm diameter) for 28 consecutive days
(‘exercise trained’, ET). Increased capillarization has been
reported within 7 days of voluntary wheel running in
skeletal muscle of C57BL/6 mice (Waters et al. 2004). A
bicycle computer (Sigma Sport, Neustadt, Germany) was
connected to the running wheel and distance, time and
speed were recorded daily. Running wheels were locked
after the 28th day of voluntary wheel running and mice
were killed at least 24 h after to ensure that the acute effects
of the last exercise bout did not influence the analysis of
VEGF protein expression. Twelve-week-old female WT
(n = 8) and AMPK DN (n = 9) mice (individually housed
since 8 weeks of age in a cage with locked running
wheels) were used as controls (‘untrained’, UT). Gastroc-
nemius and plantaris muscles were harvested and muscles
from one limb were analysed for muscle morphometry
and capillarization and the contralateral limb for VEGF
protein.
RNA isolation and real-time PCR
Total cellular RNA was isolated using commercial RNA
isolation columns (RNeasy Fibrous Tissue Kit; Qiagen,
Valencia, CA, USA). RNA was quantified with RiboGreen
reagent (Molecular Probes, Eugene, OR, USA) and stored
at −80◦C until reverse transcription. Reverse transcription
of both total RNA samples and nascent RNA from nuclear
run-on reactions was performed from 1 μg of total RNA
sample and 50 μl of nascent RNA from nuclear run-on
reactions using the High Capacity cDNA Archive Kit
(Applied Biosystems (AB), Foster City, CA, USA). VEGF
mRNA from muscle samples and transcription assays was
determined using real-time PCR, as previously described
(Gavin et al. 2006). A 5′FAM-, 3′TAMRA-labelled
TaqMan Gene Expression Assay (primer/probe set)
designed to detect all splice variants of mouse VEGF
(AB; p/n Mm00437304 m1) was used and normalized
to cyclophilin A (cycA). The cycA forward/reverse
primers (Fwd: CATCTCCGACTGTGGACAACTC; Rev:
CTGAGCTACAGAAGGAATGGTTTG) and 5′VIC-,
3′TAMRA-labelled probe (TTCTTTGACTTGCGGGC
ATTTTACCCA) were designed by Primer Express 2.0
design software (AB) using specific BLAST sequences
found in a mouse genome database (NM 008907;
Entrez, NIH, Bethesda, MD, USA) and synthesized by
Applied Biosystems. Primer/probe concentrations were
optimized and amplification efficiency was verified prior
to experimentation (data not shown). Amplicon product
size was confirmed by gel electrophoresis using a 2.0%
agarose gel stained by ethidium bromide and visualized
using ultraviolet light (data not shown). PCR reaction
mixtures (20 μl volume) contained 8 μl of diluted cDNA
template (20 ng), 1 μl each of 20X VEGF Gene Expression
Assay and 20X cycA assay set (300 nM primer, 150 nM
probe concentrations), and 10 μl 2X Universal PCR
Master Mix (AB). PCR reactions were performed in
triplicate on the Applied Biosystems Prism 7300 sequence
detection system per manufacturer’s instructions: 50◦C
for 2 min, 95◦C for 10 min, followed by 40 cycles of 95◦C
for 15 s and 60◦C for 1 min. CycA mRNA expression was
not affected by AICAR, hypoxia, exercise, or transgenic
mutation (data not shown), making cycA a valid endo-
genous control gene for these studies (Neurath et al.
2006).
Nuclear isolation and nuclear run-on assay
Nuclei were isolated from gastrocnemius muscles using
a method previously described by Hildebrandt &
Neufer (2000). Muscle tissue (∼200 mg) was rapidly
excised, chilled in 35 ml of ice-cold buffer A (15 mM
Hepes pH 7.5, 60 mM KCl, 5 mM each of EDTA and
EGTA, 3 mg ml−1 bovine serum albumin (BSA), 300 mM
sucrose, 1 mM dithiothreitol (DTT), 0.15 mM spermidine,
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0.5 mM spermine, 2 μg ml−1 leupeptin, and 0.5 mM
phenylmethylsulphonyl floride (PMSF)), thoroughly
minced, rotated at 4◦C for 5 min, and homogenized for
20 s (Polytron PT10/35, Kinematica AG, Switzerland).
Samples were allowed to settle on ice for 5 min and then
centrifuged at 700 g for 10 min at 4◦C. Crude nuclear
pellets were resuspended in 10 ml of ice-cold buffer B
(15 mM Hepes pH 7.5, 60 mM KCl, 0.1 mM each of EDTA
and EGTA, 3 mg ml−1 BSA, 300 mM sucrose, 0.5% Triton
X-100, 1 mM DTT, 0.15 mM spermidine, 0.5 mM spermine,
2 μg ml−1 leupeptin, and 0.5 mM PMSF), filtered through
pre-wetted cheesecloth, and repelleted (700 g , 10 min,
4◦C). Crude nuclear pellets were resuspended in 10 ml of
ice-cold buffer C (15 mM Hepes pH 7.5, 60 mM KCl, 5 mM
magnesium acetate, 0.1 mM each of EDTA and EGTA,
3 mg ml−1 BSA, 300 mM sucrose, 1 mM DTT, 0.15 mM
spermidine, 0.5 mM spermine, 2 μg ml−1 leupeptin, and
0.5 mM PMSF) and repelleted (700 g , 10 min, 4◦C). Crude
nuclear preparations were resuspended in 11 ml of ice-cold
buffer C/Percoll density medium (Amersham; average
density = 1.07 g ml−1) and separated from contractile
filaments by density gradient centrifugation at 27 000 g
for 15 min at 4◦C. Purified nuclei were washed in 10 ml
of ice-cold buffer C and repelleted (700 g , 10 min, 4◦C).
Final intact nuclei were resuspended in 200 μl of ice-cold
storage buffer (75 mM Hepes pH 7.5, 60 mM KCl, 15 mM
NaCl, 5 mM magnesium acetate, 0.1 mM each of EDTA
and EGTA, 40% glycerol, 1 mM DTT, 0.15 mM spermidine,
0.5 mM spermine, and 2 μg ml−1 each of leupeptin and
aprotinin) and stored at −80◦C until analysis of VEGF
transcription and genomic DNA isolation. Relative VEGF
transcription at rest and in response to acute systemic
hypoxia and acute systemic exercise was determined by a
real-time PCR-based nuclear run-on technique adapted
from previously described reports (Hildebrandt & Neufer,
2000; Pilegaard et al. 2000). Nuclear run-on reactions
were performed using 160 μl of nuclear preparation with
2X reaction buffer (20% glycerol, 10 mM MgCl2, 100 mM
KCl, 4.5 mM DTT, 1.2 mM ATP, 0.6 mM each of CTP, GTP
and UTP, 0.5 mM spermidine, 0.15 mM spermine, and
80 U ml−1 RNase inhibitor) for 20 min at 21◦C. Following
the reaction, nuclei were lysed with 10X SET buffer
(100 mM Tris pH 8.0, 50 mM EDTA pH 8.0, and 5% SDS)
and vortexing for 10 s.
Genomic DNA isolation
In order to normalize VEGF transcription and determine
the amount of starting nuclear material in each sample
for the nuclear run-on reaction, genomic DNA was
isolated from 25 μl of nuclear preparation of each sample
using commercial DNA isolation columns (DNeasy
Tissue Kit, Qiagen). Genomic DNA was quantified using
PicoGreen reagent (Molecular Probes). VEGF trans-
cription was normalized to genomic DNA content for each
sample.
Morphometric and morphological analysis
Gastrocnemius and plantaris muscles were mounted
in an OCT–tragacanth gum mixture, frozen in liquid
nitrogen-cooled isopentane, and stored at −80◦C until
processing for the measurement of muscle morphometry
and capillarization. Muscle tissue was sectioned to a
thickness of 10 μm on a cryostat, transferred to slides,
and kept at −20◦C until fixation. Sections were stained for
capillaries using a modified ATPase method (Rosenblatt),
which simultaneously provides fibre typing and capillary
visualization (Rosenblatt et al. 1987).
The gastrocnemius is a predominantly fast glycolytic
muscle and the mid-belly, white region accounts
for a large proportion of the total mass of the
gastrocnemius (Burkholder et al. 1994); therefore, only the
mid-belly, white region of the gastrocnemius was analysed
for muscle morphometry and morphology. Mid-belly
muscle sections from gastrocnemius and plantaris were
viewed under a light microscope (Nikon 400) and a
digital image taken of the superficial, white region of
the gastrocnemius and the mid-belly of the plantaris
(Nikon Coolpix 990) as previously described (Gavin
et al. 2004). Data were collected from muscle sections
by an investigator who was blinded to treatment groups.
Capillaries were quantified manually from the digital
image on individual fibres. The following indexes were
measured: (1) the number of capillaries around a fibre
(capillary contacts, CC), (2) the capillary-to-fibre ratio on
an individual fibre basis (C/Fi), and (3) the number of
fibres sharing each capillary (sharing factor). Capillary
density (CD) was calculated by using the fibre as the
reference space. Capillary-to-fibre perimeter exchange
index (CFPE) was calculated as an estimate of the
capillary-to-fibre surface area (Hepple et al. 1997).
Quantification of the capillary supply was performed
on at least 50 fibres by randomly selecting fibres in an
artifact-free region. Fibre cross-sectional area (FCSA) and
perimeter were measured with the image-analysis system
and commercial software (SigmaScan, Jandel Scientific),
calibrated to transform the number of pixels (viewed on a
computer monitor) into micrometres.
Protein isolation and analysis
Protein was isolated from approximately 30 mg of
pulverized gastrocnemius muscle and from whole
plantaris muscle. Muscle tissue was homogenized (Poly-
tron) in 300 μl of RIPA buffer (1X PBS, 1% Igepal, 0.5%
sodium deoxycholate and 0.1% SDS with protease and
phosphatase (I and II) inhibitors (Sigma)). Homogenates
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were centrifuged at 10 000 g for 15 min at 4◦C to remove
insoluble proteins and fibrous tissue and protein content
for each sample was determined using bicinchoninic acid
(BCA protein assay; Pierce-Rockford, IL, USA).
VEGF protein was purified by heparin-binding affinity
chromatography then analysed by Western blot. Protein
(200 μg) from muscle homogenates, diluted in 750 μl
of RIPA buffer with protease inhibitors, was rotated
overnight at 4◦C with 40 μl of a 50% heparin–agarose
bead slurry (Sigma; H-6508). Beads were pelleted by
centrifugation at 5000 g for 2 min and the supernatant
was discarded. Beads were washed twice in 750 μl of RIPA
buffer and beads were repelleted by centrifugation (5000 g
for 2 min) after each wash. Wash buffer was discarded and
beads were resuspended in 20 μl of 3X Laemmli buffer.
Samples were boiled for 10 min, vortexed and centrifuged
(5000 g for 30 s). Samples were separated by SDS-PAGE
on 12.5% gels then transferred to PVDF membranes.
Membranes were blocked in 5% non-fat dry milk (NFDM)
for 1 h at room temperature then incubated with VEGF
primary antibody (Santa Cruz; 1 : 1000 dilution in 5%
NFDM) for 1 h at room temperature. Immunoblots
were incubated with horseradish peroxidase-conjugated
secondary antibody (Santa Cruz; 1 : 10 000 dilution in
5% NFDM) for 1 h at room temperature. Immunoblots
were detected using ECL + Western Blotting Detection
reagent (Amersham) on autoradiography film (Midwest
Scientific, St Louis, MO, USA). Autoradiographs were
quantified by densitometry using GelPro Analyser 4.0
(Media Cybernetics, Silver Spring, MD, USA).
Statistical analysis
A two-way ANOVA was used to analyse muscle
morphology/morphometry and VEGF protein, mRNA
and transcription data. Following a significant F ratio,
Fisher’s LSD post hoc analyses were performed. For all
other variables, Student’s unpaired t tests were used to
compare differences between WT and AMPK DN. Linear
regression was performed to identify associations between
selected variables. Data are represented as mean ± S.E.M.
and statistical significance was set at P ≤ 0.05.
Results
AMPK and skeletal muscle VEGF mRNA in vivo
We investigated if AMPK can regulate skeletal muscle
VEGF mRNA expression in vivo. Acute administration
of AICAR significantly increased VEGF mRNA in the
gastrocnemius of WT, but not in AMPK DN mice
(Fig. 1A). These data demonstrate that activation of
AMPK increases skeletal muscle VEGF mRNA expression
in vivo and that the AMPK DN transgenic model used in
the current report is an appropriate model to investigate
AMPK regulation of skeletal muscle VEGF expression.
Given that systemic hypoxia increases both AMPK and
VEGF and hypoxia has been proposed as a potential
regulator of exercise-induced VEGF, we investigated
if AMPK regulates the skeletal muscle VEGF mRNA
response to hypoxia. In WT mice, acute hypoxic exposure
increased gastrocnemius VEGF mRNA compared to
normoxia. In AMPK DN mice by contrast, acute
hypoxic exposure decreased VEGF mRNA compared
to normoxia (Fig. 1B). These findings suggest that
hypoxia increases skeletal muscle VEGF mRNA through
an AMPK-dependent mechanism.
To investigate AMPK regulation of the VEGF response
to acute exercise, VEGF mRNA was measured in WT and
AMPK DN mice after an acute treadmill exercise bout.
Contrary to our hypothesis, the exercise-induced increase
in VEGF mRNA was greater in the gastrocnemius (Fig. 2A)
and plantaris (Fig. 2B) muscles of AMPK DN compared to
WT. Also in the plantaris, resting VEGF mRNA was lower
in AMPK DN compared to WT.
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Figure 1. Gastrocnemius VEGF mRNA in WT and AMPK DN mice
after acute AICAR (1 g kg−1) administration (A) or exposure to
acute systemic hypoxia (6% O2) (B)
AICAR increased VEGF mRNA in WT, but not AMPK DN mice. Acute
hypoxia increased VEGF mRNA in WT and slightly but significantly
decreased VEGF mRNA in AMPK DN mice. Data are mean ± S.E.M. WT
saline, n = 6; AMPK DN saline, n = 3; WT AICAR, n = 7; AMPK DN
AICAR, n = 6. WT normoxia, n = 16; AMPK DN normoxia, n = 24; WT
hypoxia, n = 11; AMPK DN hypoxia, n = 14. †Significantly different
from all other groups.
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To further investigate AMPK regulation of VEGF, VEGF
transcription was measured in the basal state (resting
normoxia), as well as in response to acute systemic
hypoxia or to acute exercise. Exposure to 2 h of systemic
hypoxia reduced VEGF transcription in gastrocnemius of
WT and AMPK DN mice, but acute exercise increased
VEGF transcription, compared to rest (Fig. 3A). There
was no effect of transgene on VEGF transcription in any
condition. Given that systemic hypoxia increases skeletal
muscle VEGF mRNA (in spite of reduced transcription
with hypoxia) and that the VEGF mRNA response to
hypoxia is reduced in AMPK DN mice, these findings
suggest that AMPK regulates VEGF mRNA stabilization
and not transcription.
To identify if VEGF transcription is associated
with VEGF mRNA content in skeletal muscle, VEGF
transcription was plotted versus VEGF mRNA content
in WT and AMPK DN mice in resting normoxia and in
response to acute systemic hypoxia or to acute exercise.
It is visually evident that, except for the response to
hypoxia in WT mice, there is an association between VEGF
transcription and VEGF mRNA content (Fig. 3B). Linear
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Figure 2. VEGF mRNA response to acute exercise (20 m min−1
for 60 min) in gastrocnemius (A) and plantaris (B) muscles of WT
and AMPK DN mice
Exercise increased VEGF mRNA in gastrocnemius and plantaris. In both
the gastrocnemius and plantaris the increase was greater in AMPK DN
compared to WT. In the plantaris, resting VEGF mRNA was lower in
AMPK DN compared to WT. Data are mean ± S.E.M. WT rest, n = 16;
AMPK DN rest, n = 24; WT exercise, n = 7; AMPK DN exercise, n = 7.
∗Significantly different from WT rest. †Significantly different from all
other groups.
regression, when performed excluding WT hypoxia,
revealed a significant correlation (r = 0.99) between VEGF
transcription and VEGF mRNA content with a slope no
different than 1.0 and a y-intercept slope no different than
0; suggesting that basal and exercise-induced regulation
of VEGF occurs predominantly through changes in VEGF
transcription.
AMPK and exercise-induced angiogenesis
To investigate if AMPK regulates exercise-induced
angiogenesis, WT and AMPK DN animals were exposed
to a running wheel for 28 days. There was no effect
of exercise training status (untrained (UT) or exercise
trained (ET)) on body weight; however, body weight was
lower in AMPK DN compared to WT. Exercise training
increased plantaris mass, regardless of transgene, but not
gastrocnemius mass (Table 1). Daily average running
distance was not statistically different on each day of the
training between WT and AMPK DN except on day 7,
where AMPK DN ran less than WT (Fig. 4). When analysed
for area under the curve, there was no difference between
WT and AMPK DN. In addition, there were no differences
in total distance, total time, daily time, or daily speed
between WT and AMPK DN mice over the 28 days of
voluntary wheel running (Table 2).
Gastrocnemius and plantaris muscles were analysed for
capillarization and morphometry in UT and ET WT and
AMPK DN mice. In gastrocnemius muscle (Table 3), both
CC and C/Fi were lower in untrained AMPK DN compared
to WT mice. Exercise training increased CC and C/Fi in
AMPK DN, but not in WT such that neither CC nor
C/Fi was different between WT and AMPK DN mice after
training. Exercise training increased CFPE independent
of transgene, while there were no effects of transgene or
exercise on FCSA, fibre perimeter, or CD. As anticipated,
the mid-belly portion of the gastrocnemius was composed
entirely of type IIb fibres in both WT and AMPK DN mice
and fibre-type composition did not change with exercise
training (Fig. 5A).
In plantaris muscle (Table 4), CD and CFPE were lower
in AMPK DN compared to WT independent of training
status. Exercise training increased CC, C/Fi and CFPE
independent of transgene. Exercise training increased
FCSA and fibre perimeter in WT, but not in AMPK
DN, while there was no difference in FCSA or fibre
perimeter between untrained WT and AMPK DN mice.
In untrained plantaris muscle, AMPK DN contained
fewer type IIa fibres and tended to have more type IIb
fibres (P = 0.08), compared to WT. Exercise training
increased the percentage of type IIa fibres and decreased
the percentage of type IIb fibres independent of transgene
(Fig. 5B).
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Table 1. Body weight, muscle mass and muscle mass/body weight of untrained and exercise-trained WT and AMPK DN mice
Untrained Exercise trained
P value
WT AMPK DN WT AMPK DN
(n = 8) (n = 9) (n = 8) (n = 10) Interaction Transgene Exercise
Body weight (g) 22.4 ± 0.5 21.3 ± 0.5 23.0 ± 0.4 22.1 ± 0.4 0.76 0.04 0.13
Muscle mass (mg)
Gastrocnemius 101.5 ± 2.6 97.0 ± 2.9 98.7 ± 2.3 96.0 ± 1.3 0.69 0.12 0.40
Plantaris 13.4 ± 0.3 13.1 ± 0.3 14.9 ± 0.4 14.4 ± 0.3 0.89 0.23 <0.01
Muscle mass/body weight (mg g−1)
Gastrocnemius 4.53 ± 0.07 4.34 ± 0.10 4.41 ± 0.07 4.34 ± 0.05 0.40 0.09 0.39
Plantaris 0.60 ± 0.01 0.59 ± 0.01 0.67 ± 0.02 0.65 ± 0.02 0.96 0.38 <0.01
Data are mean ± S.E.M.
To investigate if AMPK regulates the VEGF response
to exercise training, VEGF protein was measured from
the gastrocnemius and plantaris muscles in UT and ET
mice. Exercise increased VEGF protein in the gastroc-
nemius (Fig. 6C) and plantaris (Fig. 6D), independent of
transgene. VEGF protein tended to be lower (P = 0.08)
in the plantaris of AMPK DN compared to WT,
independent of training. Linear regression was performed
to identify the potential importance of VEGF protein
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Figure 3. Gastrocnemius VEGF transcription at rest
and in response to acute systemic hypoxia or to
acute exercise (A) and VEGF transcription plotted
versus VEGF mRNA content (B)
Hypoxia decreased VEGF transcription, while exercise
increased VEGF transcription. There was no effect of
genotype on the VEGF transcription response to
hypoxia or exercise. When transcription is plotted versus
VEGF content, it is visually apparent that, except for WT
hypoxia, there is an association between VEGF
transcription and VEGF mRNA content. Linear
regression, excluding WT hypoxia, revealed a strong
correlation (r = 0.99; P < 0.01) between VEGF
transcription and VEGF mRNA content, suggesting that
transcription is important for basal and exercise-induced
VEGF mRNA regulation, while stabilization is important
for VEGF mRNA regulation in systemic hypoxia. Data
are mean ± S.E.M. WT rest, n = 6; AMPK DN rest, n = 7;
WT hypoxia, n = 4; AMPK DN hypoxia, n = 6; WT
exercise, n = 3; AMPK DN exercise, n = 3. a, main
effect of hypoxia. b, main effect of exercise.
in regulating skeletal muscle capillarization. In plantaris
muscle, significant correlations between VEGF protein
and C/Fi (Fig. 7A) and VEGF protein and CFPE
(Fig. 7B) were identified. While in gastrocnemius muscle,
there was no association between VEGF protein and
C/Fi (Fig. 7C) or VEGF protein and CFPE (Fig. 7D).
These findings suggest that VEGF is an important
determinant of skeletal muscle capillarization in plantaris
muscle.
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Table 2. Voluntary wheel running over 28 days in WT and AMPK
DN mice
WT AMPK DN
(n = 8) (n = 10) P value
Total
Distance (km) 251 ± 39 212 ± 21 0.37
Time (h) 138 ± 16 118 ± 10 0.28
Daily
Distance (km) 8.96 ± 1.39 7.57 ± 0.74 0.37
Time (h) 4.9 ± 0.6 4.2 ± 0.4 0.28
Speed (m min−1) 29.4 ± 1.9 29.7 ± 0.8 0.87
Total, the total distance and time of voluntary wheel running
over the 28 day training period. Daily, the average daily distance,
time and speed of voluntary wheel running over the 28 day
training period. Data are mean ± S.E.M.
Discussion
In the present study, a mouse model with inactive skeletal
muscle AMPK was used to investigate the role of AMPK in
the regulation of skeletal muscle angiogenesis and VEGF
expression in response to exercise. The main finding of
this investigation was that AMPK is not necessary for
the angiogenic response to exercise, but is important for
basal skeletal muscle capillarization and VEGF expression.
Additionally, regulation of basal and exercise-induced
VEGF mRNA in skeletal muscle is predominantly due to
VEGF transcription and not mRNA stabilization.
AMPK and skeletal muscle capillarization
It has been proposed that the vascular supply is important
for maintaining cellular energy homeostasis (Adair, 2005)
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Figure 4. Voluntary wheel running distance in WT and AMPK
DN mice over the 28 day programme
Running distance was lower only on day 7 in AMPK DN, compared to
WT. Total running distance over the 28 day running programme was
not different between WT and AMPK DN mice. Data are mean ± S.E.M.
WT, n = 8; AMPK DN, n = 10. ∗Significantly different from WT.
and that skeletal muscle capillarization is, in turn,
regulated by metabolic demand (Hepple et al. 1997;
Frisbee, 2005). AMPK is a metabolic fuel sensor that alters
substrate utilization during periods of energy imbalance
such as occurs during exercise. Since (1) AICAR enhances
the development of collateral circulation in response to
ischaemia (Ouchi et al. 2005), and (2) inactivation of
AMPK reduces resting skeletal muscle blood flow (an
indication of lower vascularization) (Ouchi et al. 2005),
we sought to determine if AMPK regulates the angiogenic
response to exercise in skeletal muscle. Surprisingly, it
was observed that inactivation of AMPK did not alter
the angiogenic response to exercise. Taken together,
these data suggest that the mechanisms responsible for
physiological (exercise) and pathological (ischaemia)
muscle angiogenesis are different and that unique intra-
cellular signalling pathways may regulate these different
responses.
While much remains to be discovered concerning the
mechanisms that regulate skeletal muscle capillarization,
in the last decade considerable evidence has demonstrated
that VEGF is essential in determining skeletal muscle
capillarization. It has been shown that blocking endo-
genous VEGF production reduces basal skeletal muscle
capillarization 64% (Tang et al. 2004a) and inhibits
skeletal muscle angiogenesis in response to exercise
training (Wagner et al. 2005). Here, it was found
that higher VEGF protein is associated with greater
capillarization in plantaris muscle (Fig. 7A and B). In
addition, VEGF mRNA and protein were approximately
20–30% lower in resting, control muscle of AMPK DN
mice compared to WT mice, suggesting that AMPK is
responsible in part for the regulation of resting VEGF
expression. Consistent with VEGF being important for
the regulation of skeletal muscle capillarization, our
results demonstrate that inactivation of AMPK lowers
basal skeletal muscle capillarization. Since the AMPK DN
transgenic mice used in the current report are essentially
devoid of AMPK activity in skeletal muscle (Mu et al.
2001), our data suggest an important role for AMPK in the
regulation of basal VEGF expression and capillarization in
skeletal muscle in vivo.
AMPK and VEGF regulation
Lee et al. (2003) were the first to demonstrate that
AMPK regulates VEGF expression in cancer cells. It is
well established that AICAR increases AMPK activity in
skeletal muscle (Merrill et al. 1997; Musi et al. 2001).
Furthermore, inhibition of AMPK completely abolishes
AICAR-induced increases in VEGF mRNA in muscle cells
in vitro (Ouchi et al. 2005). Consistent with these findings,
AICAR increased VEGF mRNA in skeletal muscle of
WT mice, but not in AMPK DN mice (Fig. 1A), thereby
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Table 3. Skeletal muscle morphology and capillarization in the gastrocnemius in untrained and exercise-trained muscle of WT and
AMPK DN mice
Untrained Exercise trained
P value
WT AMPK DN WT AMPK DN
(n = 8) (n = 9) (n = 8) (n = 10) Interaction Transgene Exercise
Capillary contacts 4.03 ± 0.17 3.09 ± 0.23 † 4.12 ± 0.37 4.25 ± 0.20 0.03 — —
Capillary-to-fibre ratio 1.35 ± 0.07 1.04 ± 0.09 † 1.42 ± 0.12 1.46 ± 0.07 0.05 — —
Capillary density (capillaries mm−2) 708 ± 68 605 ± 94 796 ± 95 699 ± 25 0.97 0.19 0.22
CFPE (capillaries (1000 mm)−1) 7.15 ± 0.45 5.86 ± 0.65 7.68 ± 0.63 7.44 ± 0.27 0.31 0.15 0.05
Fibre area (μm2) 2167 ± 152 2113 ± 203 2207 ± 195 2356 ± 118 0.55 0.78 0.41
Fibre perimeter (μm) 194 ± 7 187 ± 9 193 ± 10 201 ± 4 0.33 0.94 0.42
Fibre-type composition (%)
Type IIb 100 100 100 100
Data are mean ± S.E.M. CFPE, capillary-to-fibre perimeter exchange index. †Significantly different from all other groups.
Table 4. Skeletal muscle morphology and capillarization in the plantaris in untrained and exercise-trained muscle of WT and AMPK
DN mice
Untrained Exercise trained
P value
WT AMPK DN WT AMPK DN
(n = 8) (n = 9) (n = 8) (n = 10) Interaction Transgene Exercise
Capillary contacts 4.46 ± 0.14 4.10 ± 0.28 5.22 ± 0.21 5.10 ± 0.24 0.60 0.30 <0.01
Capillary-to-fibre ratio 1.58 ± 0.06 1.41 ± 0.11 1.94 ± 0.09 1.88 ± 0.11 0.59 0.26 <0.01
Capillary density (capillaries mm−2) 1425 ± 104 1063 ± 73 1230 ± 106 1218 ± 90 0.08 0.05 0.83
CFPE (capillaries (1000 mm)−1) 11.17 ± 0.49 9.13 ± 0.62 11.50 ± 0.56 11.18 ± 0.30 0.09 0.02 0.02
Fibre area (μm2) 1187 ± 52 1446 ± 88 1783 ± 142 ∗ 1575 ± 128 0.05 — —
Fibre perimeter (μm) 140 ± 3 153 ± 4 172 ± 8∗ 161 ± 7 0.05 — —
Fibre-type composition (%)
Type I 21.1 ± 2.5 21.5 ± 3.7 22.1 ± 1.1 25.1 ± 1.6 0.60 0.51 0.37
Type IIa 43.4 ± 2.7 33.3 ± 2.6∗ 55.1 ± 4.1∗# 59.0 ± 2.6∗# 0.03 — —
Type IIb 35.5 ± 3.4 45.2 ± 5.0 22.8 ± 4.3∗# 15.9 ± 1.6∗# 0.04 — —
Mean ± S.E.M. CFPE, capillary-to-fibre perimeter exchange index. ∗Significantly different from untrained WT. #Significantly different
from untrained AMPK DN.
supporting the notion that AMPK is important for skeletal
muscle VEGF expression in vivo.
Hypoxia and exercise increase both skeletal muscle
VEGF expression (Minchenko et al. 1994; Breen et al.
1996; Gustafsson et al. 1999; Gavin et al. 2006) and AMPK
activity (Winder & Hardie, 1996; Hutber et al. 1997; Vavvas
et al. 1997; Hayashi et al. 2000; Gonzalez et al. 2004).
It has been suggested that hypoxia may be responsible
for increases in VEGF with acute exercise (Wagner,
2001). Therefore, we investigated AMPK regulation of
the individual VEGF responses to systemic hypoxia and
exercise in skeletal muscle. While hypoxia increased VEGF
mRNA only in WT mice (Fig. 1B), VEGF transcription
was reduced in both WT and AMPK DN mice (Fig. 3A).
Given that hypoxia is thought to be responsible for
increases in VEGF mRNA with exercise and based on
our finding that inactivation of AMPK abolishes the
VEGF mRNA response to hypoxia, we hypothesized that
inactivation of AMPK would attenuate the VEGF mRNA
response to exercise as well. Contrary to this hypothesis, it
was observed that the VEGF mRNA response to acute
exercise was greater in AMPK DN mice compared to
WT mice (Fig. 2), suggesting that inhibition of AMPK
augments the VEGF mRNA response to exercise. This
response in AMPK DN mice may be a consequence of
reduced capillarization resulting in diminished nutrient
and oxygen delivery to exercising muscle. Additionally,
exercise increased VEGF transcription in both WT and
AMPK DN mice (Fig. 3A). To the best of our knowledge,
this is the first study to report that: (1) acute exercise
increases VEGF transcription in skeletal muscle; and
(2) AMPK is not necessary for exercise-induced VEGF
expression in skeletal muscle. While it is important to
acknowledge that several other mechanisms activated by
systemic exercise could be contributing to compensate for
the lack of skeletal muscle AMPK activity in these animals,
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Figure 5. Representative photomicrographs of gastrocnemius (A) and plantaris (B) muscle sections from
untrained and exercise-trained WT and AMPK DN mice stained for capillaries and fibre type
Capillaries appear as dark-stained regions between fibres. Type IIb fibres are shown by the lightest stain, type IIa
fibres by the darkest stain, and type I fibres are intermediate. Scale bar, 100 μm.
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our data suggest that AMPK is not essential for the VEGF
mRNA response to acute exercise.
The regulation of VEGF expression is thought to occur
predominantly at the level of mRNA (Tang et al. 2004b),
such that both transcription and mRNA stabilization
may contribute to regulate VEGF mRNA in response to
hypoxia and to exercise (Tang et al. 2002). In an attempt
to further understand the regulation of VEGF mRNA
in skeletal muscle, VEGF mRNA was plotted against
VEGF transcription for gastrocnemius muscles of WT and
AMPK DN mice at rest and in response to acute systemic
hypoxia or to acute exercise (Fig. 3B). Interestingly, VEGF
mRNA levels correlate with VEGF transcription rates in
WT and AMPK DN mice for all conditions (P < 0.01),
except for WT hypoxia. Consistent with others that
report hypoxia-induced increases in VEGF expression are
the results of mRNA stabilization (Dibbens et al. 1999;
Ouchi et al. 2005); our data in skeletal muscle suggest
that: (1) increased VEGF mRNA in response to acute
systemic hypoxia is the result of mRNA stabilization
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Figure 6. VEGF protein expression in gastrocnemius and plantaris muscles of WT and AMPK DN mice at
control (Untrained; UT) and after 28 days of voluntary wheel running (Exercise Trained; ET)
A, increasing amounts of protein from gastrocnemius muscle homogenates, as well as recombinant mouse
VEGF (rVEGF), were pre-incubated with heparin beads and then a Western blot was performed under reducing
conditions. B, representative Western blot for VEGF protein in gastrocnemius muscle homogenates. C and
D, quantitative analysis of VEGF protein expression in gastrocnemius (C) and plantaris (D). VEGF protein was
normalized to WT untrained for each muscle. Exercise training increased VEGF protein in WT and AMPK DN mice
in the gastrocnemius and plantaris. In the plantaris, VEGF protein tended (P = 0.08) to be lower in AMPK DN
compared to WT mice. Data are mean ± S.E.M. MM, molecular mass (kDa), MMM, molecular mass marker. WT
untrained, n = 8; AMPK DN untrained, n = 9; WT exercise trained, n = 8; AMPK DN exercise trained, n = 10. b,
main effect of exercise.
and not increased transcription, and (2) hypoxia-induced
stabilization of VEGF mRNA is AMPK dependent. Taken
together, these data support our conclusions that VEGF
expression at rest and in response to exercise is trans-
criptionally regulated, but in acute systemic hypoxia VEGF
is regulated via mRNA stabilization.
Hypoxia-inducible factor-1 (HIF-1) is thought to
be an important transcriptional regulator of VEGF
expression in response to low oxygen stress. Ameln et al.
(2005) demonstrated that exercise stabilizes and induces
the nuclear translocation of HIF-1α and studies from
cancer cells demonstrate that AMPK is necessary for
HIF-1-dependent transcriptional activity of VEGF (Lee
et al. 2003; Neurath et al. 2006). However, abolishing
HIF-1α does not alter skeletal muscle VEGF mRNA levels
(Mason et al. 2004). In fact, untrained HIF-1α null mice
display a similar muscle phenotype to that of wild-type
mice after exercise training (i.e. increased capillarization),
a consequence the authors attributed to elevated AMPK
activity in resting HIF-1α null muscle (Mason et al.
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2007). Consistent with this, our results argue against the
transcriptional regulation of VEGF via AMPK and HIF-1
in skeletal muscle in response to exercise and suggest that
systemic hypoxia and systemic exercise function through
different mechanisms to increase VEGF mRNA in skeletal
muscle in vivo. It is well documented that VEGF is
essential for the maintenance and expansion of skeletal
muscle capillarization (Tang et al. 2004a; Wagner et al.
2005); however, taken together, these results question
the importance of HIF-1α for exercise-induced VEGF
expression and angiogenesis in skeletal muscle.
AMPK, exercise and fibre-type transitions
Voluntary wheel running is an appropriate model to
investigate adaptations to exercise training as increases in
skeletal muscle capillarization have been reported within
7 days of running in C57BL/6 mice (Waters et al. 2004).
No significant differences were observed in: (1) speed
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Figure 7. Relationship between VEGF protein and skeletal muscle capillarization in gastrocnemius and
plantaris of untrained and exercise-trained WT and AMPK DN mice
Greater VEGF protein is associated with greater capillary-to-fibre ratio (A) and greater capillary-to-fibre perimeter
exchange index (B) in plantaris. VEGF protein is not associated with capillary-to-fibre ratio (C) or capillary-to-fibre
perimeter exchange index (D) in gastrocnemius. UT, untrained; ET, exercise trained; CFPE, capillary-to-fibre
perimeter exchange index; AU, arbitrary units.
or time to exhaustion with treadmill running or (2)
distance or time over the 28 days of voluntary wheel
running between WT and AMPK DN mice (Table 2);
however, previous studies have reported decreased exercise
tolerance and voluntary activity levels in AMPK DN mice
(Mu et al. 2001, 2003). The authors partly attributed
the exercise intolerance in AMPK DN mice to reduced
muscle glycogen. While muscle glycogen was reduced
∼25% in AMPK DN mice (data not shown), in our hands,
the AMPK DN mice displayed no significant exercise
intolerance, despite having lower basal capillarization (an
important determinant of V̇O2max; Ingjer, 1978).
Exercise training induces fibre-type transitions from a
more glycolytic phenotype to a more oxidative phenotype.
More specifically, type IIb fibres transition to type IIa
fibres, but type IIa fibres do not typically transition to
type I fibres with normal exercise training (Luginbuhl
et al. 1984). Consistent with our data, Waters et al.
(2004) reported significant fibre-type transitions with
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voluntary wheel running in plantaris muscle of C57BL/6
mice. Since the AMPK DN transgene is driven by the
MCK promoter, which is preferentially active in fast,
type II muscle fibres (Chin et al. 1998), we chose to
analyse only the gastrocnemius and plantaris muscles
for these studies. AMPK has been proposed as a major
mediator of skeletal muscle plasticity (Nielsen et al. 2003).
Röckl et al. (2007) indicated that AMPK is important
for exercise-induced fibre-type transformations in triceps
brachii muscle. We also observed fibre-type transitions
to a more oxidative phenotype (IIb → IIa) with exercise
training, but there was no difference in fibre-type
transition between WT and AMPK DN. Interestingly,
our results demonstrate that plantaris muscle of AMPK
DN mice displays a faster, less oxidative phenotype in
the untrained state, compared to WT mice. Chronic
AICAR administration increases (Winder et al. 2000) and
inactivation of AMPK decreases (Jorgensen et al. 2007)
mitochondrial enzyme content in muscle. AMPK activates
peroxisome proliferator-activated receptor (PPAR) and
PPAR coactivator-1α (PGC-1α) (Lee et al. 2006),
important factors for the control of mitochondrial
biogenesis. It is possible that lack of AMPK activation
of PPAR and PGC-1α may play a role in the faster,
less oxidative phenotype in untrained plantaris muscle
of AMPK DN mice. Our data suggest that AMPK is
not necessary for exercise-induced fibre-type transitions,
but does appear to be important for determining basal
fibre-type composition. Consistent with this notion,
Jorgensen et al. (2007) concluded that AMPK may not be
essential for metabolic adaptations to exercise training, but
AMPK is important for basal expression of mitochondrial
enzymes.
The Rosenblatt technique is limited to the detection of
type I, IIa and IIb fibres and does not identify IIx fibres.
When mATPase histochemical and immunohistochemical
identification of fibres types are compared, type IIx fibres
are identified as IIa (Gorza, 1990). Thus, the findings in
the current report may overstate the percentage of IIa
fibres. It should be noted though that in mice, types IIa
and IIx fibres demonstrate similar oxidative capacities
as measured by succinate dehydrogenase (SDH) activity
(Gorza, 1990) and thus the resultant phenotypes should
be similar regardless of the identification of fibres as
type IIa or IIx.
In conclusion, we have demonstrated that in skeletal
muscle in vivo: (1) AMPK regulates the maintenance
of basal capillarization, but not exercise-induced
angiogenesis; (2) AMPK regulates basal VEGF expression;
and (3) regulation of basal and exercise-induced VEGF
mRNA is predominantly through the regulation of
mRNA transcription and not stabilization. Taken together,
these results suggest that AMPK plays an important
role in basal VEGF expression, capillarization, and
fibre-type composition; but AMPK is not necessary for
the angiogenic responses to exercise training in skeletal
muscle.
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